Bacterial biofilm infection is a common (~ 2 to 4%) complication for recipients of surgically implanted medical devices. Due to the tremendous increase in antibiotic resistance when these bacteria enter the biofilm phenotype, present treatment requires explantation and replacement of the device, often with multiple surgeries and always with much longer patient recovery time. The specific objective of this study was to quantify the degree of deactivation of biofilm from exposure to thermal shock for varying temperature and time durations. While extreme temperature (>150˚C) is routinely used to sterilize (e.g. autoclaves), such temperatures have a severe cost within the body. Despite extensive studies on thermal deactivation of bacteria in the planktonic phenotype over a wide range of temperatures (e.g., pasteurization protocols), surprisingly little is known about the thermal deactivation of biofilms except under extreme conditions. Here, the deactivation of Pseudomonas aeruginosa biofilms is reported. These biofilms were cultured in two ways, using a batch mode setup with an orbital shaker and with a continuous drip-flow reactor (DFR). These two culturing techniques resulted in different biofilm architecture and a bacteria concentration 350 times higher for the DFR biofilms. The DFR biofilms, becoming the focus of the study, were cultured at 37°C for 24 hours and subjected to heat shocks on the range of 50°C to 80°C for durations of 1 to 30 minutes. Heat shocks were delivered by immersion in thermostatted media for the prescribed time and the resulting concentration of colony forming units (CFU/cm 2 ) were quantified using direct enumeration. Up to 6.6 orders of magnitude reduction in CFU concentration was observed, indicating that thermal deactivation is a reasonable approach to biofilm mitigation. Integrating this approach with a magnetic nanoparticle implant coating will result in an innovative treatment for implant infections in situ without explantation or device replacement.
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Introduction and background
Biofilm formation due to a nosocomial infection is a serious issue for implanted medical devices.
Many sterilization protocols have been put in place to help reduce the occurrence, but the problem persists. The typical treatment of these infections is to have subsequent surgeries to explant and replace the device, as well as administer antibiotics to mitigate the bacteria. However, this approach is not eliminating the problem because infection occurrence persists and the number of procedures continues to grow (Burke 2003 , Darouiche 2004 , Wisplinghoff, Bischoff et al. 2004 , Ammerlaan, Harbarth et al. 2013 ). This results in increased recovery time and medical expenses for the patient. Therefore, it is desirable to develop a new and innovative treatment for biofilm deactivation.
What is a biofilm?
The biofilm phenotype is an aggregation of bacterial cells that stick on a surface, characterized by its layer-like structure and surrounding polysaccharide matrix. It is differing from the freefloating, planktonic phenotype. The biofilm architecture in general is heterogeneous throughout and constantly changing as the biofilm colonizes and grows (Zoubos, Galanakos et al. 2012 ).
Biofilm formation is usually broken down into five stages of growth (Drenkard and Ausubel 2002 , Hall-Stoodley, Costerton et al. 2004 , Zoubos, Galanakos et al. 2012 . The first stage is the initial attachment of bacterial cells to the surface. Stage two is the accumulation of cells, as the bacteria concentration starts to increase. Stage three is the initial secretion and development of the polysaccharide matrix. Stage four is the maturation of the biofilm and its overall heterogeneous architecture -thickness and bacteria concentration varying throughout the colony. The final stage is the re-release of bacteria as the biofilm continues to spread and colonize other surfaces.
During these growth stages and phenotypic switch, the bacteria are increasing their resistance to many means of chemical treatments -specifically antibiotics.
Biofilms colonize approximately 2 to 4% of the 3.6 million implanted devices annually in the U.S. (Darouiche 2004) . Treatment can cost anywhere from $15,000 to $50,000 per surgery, totaling an extra $5 billion in annual medical expenses (Darouiche 2004) . The patient has also been shown to be more susceptible to a second infection after treating the original Costerton 2001, Drenkard 2003) . For example, 1.5-2.5% of total hip and knee replacements develop joint infections upon primary implantation. After replacement, the rates increase to 3.2-5.6% (Rohde, Burandt et al. 2007 ). The main reasons these infections are difficult to treat is because of the biofilm's antibiotic resistance which make it up to 1000-fold less susceptible to antibiotics than planktonic cells (Nickel, Ruseska et al. 1985 , Costerton, Lewandowski et al. 1995 , Vinh and Embil 2005 .
Antibiotic resistance of biofilms
A biofilm's antibiotic resistance is attributed directly to the biofilm phenotype. This resistance should not be confused with evolutionary antibiotic resistance seen from overuse of antibiotics and the development of resistant genes in antibiotics (Levy 1998) . While it is still not completely understood why the biofilm phenotype shows increased antibiotic resistance, it is hypothesized that the reasons are multifactorial (Costerton, Lewandowski et al. 1995 , Drenkard 2003 . These factors include transport limitation, physiological gradients, development of persister cells, changes in quorum sensing (QS) systems, triggering the stress response, and up-regulation of multidrug efflux pumps (Drenkard and Ausubel 2002, Drenkard 2003) .
The polysaccharide matrix of the biofilm plays a large role in the transport limitation of antibiotics and biocides, as well as physiological necessities such as oxygen and nutrients. The matrix not only adds a physical barrier, but also has been shown to react with various chemical treatments and render them unreactive (Mah and O'Toole 2001, Imaizumi, Tran et al. 2003) . This depends on the type of antibiotic being administered and the different strains of bacteria comprising the biofilm. For example, Pseudomonas aeruginosa biofilm has been shown to slow delivery of aminoglycosides but not fluoroquinolones (Stewart 2002) . The charge of the antibiotic is also important since positively charged species will bind to the negatively charged matrix therefore slowing diffusion (Stewart and Costerton 2001) . Limitations of oxygen and nutrients are also attributed to the biofilm matrix. Bacteria located on the outer layers of a biofilm have better access to nutrients and therefore a higher metabolic rate than bacteria located near the center of a biofilm. This lower metabolic activity results in these bacteria being in a dormant state and thus not up-taking the antibiotics. Also certain antibiotics, such as penicillin, only target bacteria in a growth stage (Stewart and Costerton 2001) .
The development of persister cells can be a result of the biofilm phenotype change and QS systems. QS is the cell-to-cell communication in biofilms as bacteria concentration increases on a surface. It triggers signaling by N-acyl homoserine lactones (for gram-negative bacteria), which diffuse across the cell membrane and bind to regulatory proteins within the cell (Kalia 2013 ).
This signaling can result in the formation of the biofilm matrix and persister cells. These cells have been shown to continue to thrive through repeated and prolonged antibiotic exposure. It is thought that they are able to accomplish this by altering their typical programmed cell death (PCD) that is usually experienced when exposed to certain antibiotics. For example, it was shown that P. aeruginosa biofilms when exposed to fluoroquinolones, results in a decreased viable bacteria population of 1,000 -to 100,000 -fold, but continuous increase of the antibiotic concentration indicates any viable cells remaining are completely resistant (Lewis 2000) . When they do not follow the normal PCD, they are able to resist antibiotics and continue the biofilm's colonization.
Biofilm bacteria also activate the general stress response during development. This is due to environmental stresses, DNA damage, osmotic variations, oxidative changes, etc. (Drenkard 2003) . The stress response causes higher expression of the sigma factor rpoS, which activates a number of genes necessary to maintain cell viability during stationary phase (Xu, Franklin et al. 2001, Wang and Wood 2011) . The signaling of this sigma factor enables protection from environmental stressors, which would include antimicrobial agents.
A final contributing factor to antibiotic resistance is the up-regulation of multidrug efflux pumps.
Efflux pumps help stabilize the bacteria by pumping out toxins such as antimicrobial agents, metabolites, and QS signal molecules such as N-acyl homoserine lactones (Pearson, Van Delden et al. 1999 , Aeschlimann 2003 , Soto 2013 . When these pumps are up-regulated, it is harder to target antibiotics to the biofilm (Soto 2013) . What is not fully understood is what causes the different pump systems to turn on and off (Aeschlimann 2003 , Piddock 2006 ).
In general, biofilms have been shown to be antibiotic resistant for many reasons. Further complicating matters, the biofilm may host multiple species of pathogens, each with different resistance characteristics (Watnick and Kolter 2000, Stoodley, Sauer et al. 2002) . These biofilmspecific resistance problems suggest an inherent limit on the effectiveness of current chemical approaches to biofilm deactivation.
Biofilm treatment and prevention
Recent attempts for combatting biofilms include biocide loaded polymer device coatings, which attempt to keep the bacteria from ever colonizing (Kingshott and Griesser 1999 , Smith 2005 , von Eiff, Jansen et al. 2005 , Pavithra and Doble 2008 , quorum sensing inhibitors (Davies 1998 , Boles and Horswill 2008 , Kalia 2013 , electrical current (Blenkinsopp, Khoury et al. 1992, Van Der Borden, Van Der Werf et al. 2004) , extracorporeal shock waves (Gerdesmeyer, von Eiff et al. 2005) , photodynamic therapy (Di Poto, Sbarra et al. 2009 ), and magnetic field exposure (without added magnetic material) (Stewart, Wattanakaroon et al. 1999 ).
Polymer coatings on medical implants usually employ the addition of functional groups in order to deter bacteria adhesion and accumulation from ever happening. A common example of a functional group addition is poly(ethylene glycol) (PEG). While PEG has shown to decrease the adhesion of proteins, it is not always successful at keeping bacteria from colonizing. It is also easily oxidized leaving the material susceptible to colonization (Cheng, Zhang et al. 2007 ).
Therefore, biocompatibility of the material is an important consideration. Zwitterionic polymer coatings have also been developed as alternatives to PEG coatings because of their broader chemical diversity (Mi and Jiang 2014) . They use a homogenous distribution of anionic and cationic groups on a polymer backbone, typically methacrylate or acrylamide, resulting in an ultra-hydrophilic and neutrally charged polymer. However, the polymer alone is not sufficient to keep bacteria from colonizing so antibiotics have been added as leaving groups on the polymers in order to increase anti-fouling efficacy (Mi and Jiang 2012) . Different materials have been used in various medical applications but there is not one that appears to be universally applicable for biofilm prevention (Pavithra and Doble 2008) .
QS system inhibitors have been a developing area of interest for biofilm prevention. The concept is straightforward -biofilm development would be prevented if cells were not allowed to communicate with each other as population density increases. Issues arise, however, when targeting QS signal receptors, as many strains have multiple receptors to inhibit (Kalia 2013) .
Also, even after QS systems are interrupted, an accumulated population of bacteria is already colonized on the surface, leading to a vulnerable starting state for treatment.
All of the other prevention methods mentioned above (electrical current, shock waves, photodynamic therapy, and magnetic field exposure) rely on a complementary means of treatment (such as antibiotics) to be successful. Plus none of these methods have shown to mitigate all pathogens or be effective and easy to accomplish in vivo. Therefore, it would be more encouraging to develop a high deactivating, sole means of treatment that could be readily and safely performed in vivo.
Thermal sterilization
Thermal sterilization is a well-established concept and is based on the fact that every organism has a ceiling temperature for survival. For example, typical pasteurization involves heating milk to 72 ˚C for 15s in order to kill bacteria, and thermal sterilization of common pathogens like P. aeruginosa in its planktonic phenotype have been studied at 50 -60 ˚C (Hassani, Álvarez et al. 2005 , Hassani, Manas et al. 2007 . Less common are studies of thermal sterilization of biofilms, even in non-medical applications where arbitrarily high heating can be conveniently applied. One group has developed a predictive model for heat inactivation of Listeria monocytogenes biofilms on food processing equipment Frank 2004, Chmielewski and Frank 2006) , and another group has shown magnetic nanoparticles can heat biofilms (Park, Park et al. 2011) .
Otherwise thermal sterilization studies have commonly been accompanied by chemical and mechanical means. A study has not been conducted to quantify deactivation based on specific temperature protocols alone. Within the human body, such indiscriminate methods such as oxidizers and high-shear scrubbing are unadvised and simply heating the biofilm becomes a challenge. For devices without large batteries and wireless telemetry, the heating energy must be supplied from outside the body. Being able to remotely heat a biofilm, would result in an innovative, less invasive treatment method. Determining the physiologically relevant heat shock protocols (time and temperature combinations needed for deactivation) is the initial step to display this proof of concept.
Objectives
The long-term goal of this research is to develop an innovative treatment for eliminating biofilm infection via remote heat sterilization. This heat in the future will be supplied wirelessly by coating the implanted device with a magnetic nanoparticle-loaded polymer coating and exposing the device to an external magnetic field (Figure 1 ). The magnetic field will cause the particles to heat-up and this will thermally deactivate the biofilm on the surface of the implant. To establish this treatment, it is necessary to first determine the combination of heat shock temperature and duration necessary for the level of deactivation that mitigates the biofilm. This research focuses on this task through the following objectives:
1. Develop biofilm culturing protocol.
2. Evaluate the potential of different biofilm architectures and bacteria loading using confocal laser scanning microscopy and direct enumeration quantification, respectively.
3. Develop a heat shock process that minimizes thermal inertia and instantaneously applies a thermal shock to the biofilm.
4. Determine the heat shock time and temperature combinations needed to reach different levels of log reduction of viable bacteria. This will lead to the ability to approximate the extent of deactivation based on thermal protocol. This project has the potential to help hundreds of thousands people annually that develop an infection of their implanted medical device. The experiments will develop biofilms, deactivation and quantification procedures, and ultimately result in an innovative treatment for biofilminfected implants.
Materials and methods
Biofilms were cultured by two different methods and then heat shocked for varying temperature and time combinations, ranging from 50°C-80°C and durations from 1 to 30 minutes respectively.
Post heat shock, biofilms were quantified via direct enumeration and their log reductions were calculated.
All experiments and preparation work were completed in a biosafety level 2 room and precautions were taken when addressing cleaning and contamination. This includes the use of appropriate personal protective equipment including eye protection, lab coat, and nitrile gloves sterilized with 75% by volume ethanol in water. All organism isolation and quantification of bacteria was completed in a biosafety cabinet. Lab waste such as pipette tips and incoluating loops were single use pieces and autoclaved prior to trials. Waste was also autoclaved prior to disposal. Media was also autoclaved in order to ensure sterility and only openly exposed in the biosafety cabinet. Heat shocks were completed in a water bath system (see Heat shock system section below for details) with deionized water and dishes were sealed with parafilm to avoid contamination. All instrumentation was routinely and thoroughly cleaned with 10% by volume bleach in water solution and 75% by volume ethanol in water.
Organisms and media
The pathogen Pseudomonas aeruginosa was chosen for this investigation. It is commonly associated with nosocomial infections and often used in biofilm research (Drenkard and Ausubel 2002 , Borriello, Werner et al. 2004 , Pierce 2005 , Gellatly and Hancock 2013 . It is also shown to be highly resistant to antibiotics when present as the biofilm phenotype (Drenkard and Ausubel 2002, Gellatly and Hancock 2013) . Specifically, reference strain 16952 (American Type Culture Collection, Manassas, VA) was used, which is PA01 Pseudomonas aeruginosa and non-mucoid.
It was isolated from frozen glycerol stock cultures and streaked on agar-filled plates (Difco Nutrient Agar, Sparks, MD). The streaking was done in a biosafety cabinet and occurs in three different streaks, using three sterile inoculating loops (VWR, Radnor, PA). Each streak pulls from the last part of the previous streak in order to dilute the bacteria throughout each streaked section of the agar plate -leaving the third section the most dilute and able to grow individual colony forming units (CFUs). After streaking, the plates were incubated for 24 hours at 37°C, and then a single colony was used to inoculate 5 mL of tryptic soy broth (TSB; BD Bacto, Sparks, MD) with a sterile inoculating loop in a standard 15 mL test tube. Single colonies were used to best control starting inoculum concentration for biofilm culturing as well as genetic variations due to bacteria replication. The TSB was sterilized prior to inoculation at 121°C for 15 minutes in an autoclave.
The 5 mL of inoculated TSB was incubated at 37°C for 24 hours, which results in a bacterial concentration of approximately 10 9 CFU/mL (see Growth study below for methods). This inoculum was then used for biofilm culturing. All streaking waste was autoclaved prior to disposal.
Glucose-enhanced media was used in the shaker biofilm cultures that resulted in biofilms with less dense bacteria concentrations than biofilms grown using TSB (see Shaker biofilms in the Results section). To make 500 mL of media (all ingredients from Fisher Scientific, Waltham, MA), 4.3 g of potassium monophosphate, 2.7 g potassium phosphate dibasic, 0.024 g magnesium sulfate, 0.00144 g ferrous sulfate heptahydrate, and 5.232 g MOPS free acid were dissolved in 500 mL of purified water. This solution was then vacuum filtered (VWR, Radnor, PA) to ensure sterility.
Growth study
In order to verify that the inoculum was at a consistent concentration and in stationary phase before starting biofilm culturing, a growth study was done on P. aeruginosa strain 16952. The strain was isolated as previously described from the frozen glycerol stock and streaked on an agar-filled plate in the biosafety cabinet. The plate was incubated for 24 hours at 37°C, and then a single colony was used to inoculate 5 mL TSB. The inoculated broth was kept sealed at 37°C, 5%
CO2 and evaluated over a 36 hour period. Samples taken at various time points during the study with sterile pipette tips were serially diluted with clean broth to an appropriate dilution factor based on how long the sample had already been incubated and the expected CFU/mL. The samples were quantified by both direct enumeration (see Direct enumeration of bacteria below)
and by ultraviolet-visible (UV-VIS) spectrophotometric scans. UV-VIS (Varian Cary 50, Walnut
Creek, CA) scans were done from 200 to 800 nm -focusing on the optical density (OD) at 600 nm because of the broth's yellow color and the common use of this wavelength in growth studies and bacterial turbidity measurements. After quantification, the samples were autoclaved prior to disposal.
Biofilm characterization via Confocal Laser Scanning Microscopy
Confocal Laser Scanning Microscopy (CLSM) was used to image biofilms in order to evaluate thickness and architectural characteristics. CLSM is an imaging technique that utilizes the fact that only light at a certain depth reaches the detector. Multiple images can be taken throughout a sample as the focal plane is moved to different depths. Rendering these slices together creates an overall three-dimensional image.
The biofilms were imaged by CLSM using fluorescent dyes. The fluorescent stains used for P.
aeruginosa are based on DNA binding and membrane integrity. The live bacteria are stained with SYTO 9 which complexes with DNA, and when bound, causes the bacteria to fluoresce green.
SYTO 9 also stains dead bacteria, but if the bacteria has a disrupted membrane, another stain, propidium iodide, is also allowed into the cell, quenching the green fluorescence and fluorescing red itself. The dyes were from the LIVE/DEAD BacLight™ Bacterial Viability Kit (Invitrogen, Eugene, OR), which calls for a 1:1 ratio of Component A (SYTO 9 dye 3.34 mM) to Component B (propidium iodide 20 mM) for the staining procedure.
The CLMS used was an upright Bio-Rad 1024 confocal microscope (Hercules, CA) at Central
Microscopy Research Facility at the University of Iowa with a 40x dip lens. The dip lens was cleaned pre and post sample exposure using sterile cotton swabs and 75% by volume ethanol in water. Krypton/argon mixed gas lasers of 488 and 568 nm excited the SYTO 9 and propidium iodide dyes, respectively. The lasers were used sequentially to avoid any overlap in the emission of fluorescent light from the stains. The microscope created an overall image based on the average of four scans, a z-step of 1 μm, 256 intensity levels, and 512x512 pixel count. All parameters were set using the Bio-Rad software. The slices were then rendered together to create a three-dimensional image of the biofilm using the Java-based, public domain image processor, ImageJ (National Institutes of Health, Bethesda, MD). Imaged biofilms were disposed of by autoclaving.
Direct enumeration of bacteria
Direct enumeration is a common means of quantifying bacteria by serially diluting a sample, plating it, and then allowing CFUs to grow for counting. All enumeration was done in the biosafety cabinet with single use, autoclaved pipette tips. Growth study samples were thoroughly mixed by inverting ten times. Serial dilutions were set up by using 900 μL of TSB in each test tube and then adding 100 μL of undiluted sample to the first tube. Pipetting up and down ten times mixed the dilution, and then 100 μL of the first tube was put into the second tube of 900 μL TSB. This process was repeated until all dilutions were completed. Each dilution reduces the CFU concentration by a factor of 10. After diluting, a 100 μL sample from each tube was spread over an agar-filled petri dishes using 4 mm diameter glass beads (Biochemistry Stores at the University of Iowa, Iowa City, IA). The glass beads were discarded after spreading each plate.
After spreading the sample, the CFUs were incubated for 24 hours at 37°C. Then the CFU/mL for the original sample were back calculated using the following equation:
Shaker biofilm cultures Shaker biofilms were grown using the 5 mL of inoculated TSB at a bacteria concentration of 10 9 CFU/mL. They were cultured in a 4-well polystyrene rectangular dish (Thermo Scientific Nunc, Rochester, NY) with a frosted glass microscope slide on the bottom of each well (Leica, Buffalo
Grove, IL). Glucose-enhanced media was added to the well along with inoculum in a 5:0.33 mL ratio, respectively. The dishes were then sealed with parafilm (Bemis Company, Inc., St. Louis, MO) and placed on an orbital shaker (VWR, Radnor, PA) for 72 hours, 37°C at approximately 150 rpm and an orbital diameter of 15 mm. After 72 hours of growth, the biofilms had an average cell density of approximately 2.67 x 10 6 CFU/cm 2 . The general setup for shaker biofilms can be seen in Figure 2 . There was more variation in biofilm growth for the shaker biofilms compared to the drip flow reactor biofilms. Sampling techniques for controls needed to be considered for these trials. One slide from each dish was reserved for heat shocking at control conditions of 37°C. The heat shock temperatures considered were 50°C and 80°C, covering the extremes of the investigative temperature range. The heat shock durations were 2, 10, or 30 minutes. All quantification was done using direct enumeration. 
Drip flow reactor (DFR) biofilm cultures
Biofilms were grown in an incubated (37°C) drip flow reactor (DFR), which has ASTM standard E2647-08 associated with it (BioSurface Technologies Corporation, Bozeman, MT). The DFR gravitationally allows fresh TSB media to flow through the four reactor wells due to its 10° downward slope. The reactor wells had frosted glass microscope slides in them for biofilm attachment and growth.
The biofilm formation and growth progressed through two stages, batch and continuous mode.
Batch mode had the incubated DFR at zero incline for 4 hours with a 1:15 mL ratio of inoculum to fresh TSB in each well to allow bacteria concentration to attach and accumulate on the microscope slide surface. After batch mode, the DFR was put into continuous mode for 24 hours, which utilized the 10° incline and peristaltic pump to drip clean TSB through the wells at a rate of 5L/day (Figure 3 ). This resulted in a consistent biofilm, approximately 50 -100 µm thick (see Biofilm Characterization via CLSM in results for details) and a cell density of 1.65 x 10 9 CFU/cm 2 .
Figure 3 -General setup for drip flow reactor (DFR) biofilms. DFR biofilms were grown in a 4-well reactor (A) incubated at 37°C. TSB media flowed at a rate of 5L/day for 24 hours via a peristaltic pump through the wells (B). This setup results in an average bacteria concentration of 1.65 x 10
9 CFU/cm 2 .
Heat shock system
In order to have instantaneous, homogeneous, thermal shock, the biofilm thermal deactivation occurred in a water bath heat shock system (Figure 4 ). The water bath was allowed to stabilize at a given investigative temperature with polystyrene 4-well rectangular dishes, containing 5 mL of media per well, sealed with parafilm to avoid contamination and submerged in the bath. The biofilms were transferred to the heat shock system from the DFR or shaker plates via the frosted microscope slide, on which they had been growing, into the 4-well heat shock dish. The heat shock dish was resealed, submerged, and maintained at the elevated temperature for a given time interval. Temperature in the wells was verified and monitored using thermocouples (two in each of the 4-well dish; type T). Immediately following the thermal shock, the biofilms were removed via the frosted microscope slide from the 4-well heat shock dish and placed into a fresh polystyrene 4-well dish with 5 mL of media at room temperature and then immediately quantified. The heat shock temperatures investigated were 37°C (for control evaluation purposes), 50°C, 60°C, 70°C, or 80°C and the heat shock durations were 1, 2, 5, 10, 15, 20, or 30 minutes.
Quantification via direct enumeration
Direct enumeration was used to quantify biofilms because of its ability to precisely quantify viable bacteria concentrations on a logarithmic scale. Other techniques such as microscopy only work on an arithmetic scale, limiting quantification reduction to one order of magnitude. The 4-well dish containing the deactivated biofilms at room temperature were sealed and sonicated (VWR, Radnor, PA) for 10 minutes, 45 kHz, 240 W in order to disrupt the polysaccharide matrix and homogenize the bacteria. After sonication, a 100 µL sample was taken directly from each of the 4 wells, serially diluted, and plated on agar-filled petri dishes. Plating was done using the spread plate technique with glass beads. The petri dishes were incubated at 37°C for 24 hours, and then the CFU were counted for each plated dilution. From the collected plate counts, the number of viable bacteria in the biofilm were back-calculated based on CFU count per plate and the dilution factor. All analyses are performed on the log(CFU) and not the CFU directly since parameters vary on a logarithmic scale.
Statistical analysis
All statistical analysis was completed using JMP 11.2 statistical software. Means comparison were done using a one-way ANOVA Tukey-Kramer method with α = 0.05. A one-way ANOVA tests the null hypothesis that means from different groups are the same. The Tukey-Kramer method compares all pairs of means to test if they are significantly different based on a critical value of α The data is reported as the average log(CFU/cm 2 ) ± standard deviation.
Results
Growth study
Observing inoculum growth over a 36-hour period showed the inoculum entered and continued in stationary phase after a 24-hour incubation (37°C, 5% CO2). It was consistently at 1.7 x 10 9 CFU/mL (±1.04 x 10 8 standard deviation), Figure 5 . Completing UV-VIS scans over the range of 200 to 800 nm and focusing on OD at 600 nm resulted in OD600 equal to approximately 0.6 after 24-hour incubation. The inoculum was always cultured for 24-hours, ensuring it had reached a constant stationary phase concentration of approximately 10 9 CFU/mL. Having an invariable starting inoculum leads to more uniform biofilm growth for experimental heat shocks.
Shaker biofilms
P. aeruginosa biofilms were grown in sealed, batch conditions using 4-well polystyrene dishes.
Each well had a frosted microscope slide in it, enabling easy biofilm transfer from the growth environment to the heat shock system. The plates were agitated using an orbital shaker to encourage biofilm formation during growth. One slide from each dish was reserved for heat shocking at control conditions of 37°C. The heat shock temperatures considered were 50°C and 80°C, covering the extremes of the investigative temperature range. The heat shock durations were 2, 10, or 30 minutes. All quantification was done using direct enumeration. The controls had a grand mean of 6.24 log(CFU/cm 2 ), i.e. . Therefore, the minimum quantifiable log(CFU/cm 2 ) is 1.12. However, the undiluted, heat-shocked biofilms samples were yielding less than five CFU per plate (often zero CFU) indicating that thermal deactivation reduced the log(CFU/cm 2 ) lower than the minimum of 1.12. A more robust and denser starting population was needed in order to be within quantifiable threshold limits. Therefore, biofilms with denser bacteria loading were pursued using the DFR.
Drip flow reactor control biofilms
P. aeruginosa biofilms grown in DFRs were denser and more robust. Their growth conditions were at 37°C using TSB as the media source and a flow rate of 5L/day for 24 hours. Each reactor had 4-wells with frosted microscope slides in the bottom for biofilm attachment and transferring.
Control biofilms were evaluated in order to verify consistency of processing steps as well as the starting bacteria concentrations of the heat shock experiments. Post growth, the controls were transferred to the heat shock system which was stabilized at 37°C for a duration of 1, 2, 5, 10, 15, 20, or 30 minutes and then quantified by direct enumeration. Comparing the means using the oneway ANOVA Tukey-Kramer method (α = 0.05) at each time point showed there was no statistical difference between controls ( Figure 7 ). The grand mean for the controls was 8.553 log(CFU/cm 2 ).
The average thickness of the biofilms varied from 50 -100 μm (measured by CLSM imaging, see 2, 5, 10, 15, 20, or The DFR biofilms produced were consistent and 350 times denser, based on bacteria concentration, than the shaker biofilms and more than twice as thick. These biofilms were also visually different than shaker biofilms. They had a tackier matrix and covered the entire microscope slide, whereas the shaker biofilms were easily sheared and patchy over the microscope slide area.
Biofilm characterization via CLSM in the Results section below).
Biofilm characterization via CLSM
Using CLSM to characterize biofilms showed there was a difference in thickness and architecture between shaker and DFR biofilms. Shaker biofilms were approximately 25 to 45 µm thick with a control grand mean bacteria concentration of approximately of 6.24 log(CFU/cm 2 ), while DFR biofilms were approximately 50 to 100 µm thick with a control grand mean 8.59 log(CFU/cm 2 ).
The shaker biofilms were also less viscous and only covered patchy sections of the microscope slide sample, while the DFR biofilms produced higher coverage by colonizing the entire slide. Figure 8A and 8B depict examples of controls for a shaker and DFR biofilm, respectively, representing the difference in coverage and thickness. To show the contrast between heat shocked and control samples, DFR biofilms were heat shocked at 80°C for 30 minutes and imaged as described above. Figure 9A shows the control that was heat shocked at 37°C for 30 minutes, while Figure 9B displays the heat shocked biofilm at 80°C for 30 minutes. The level of deactivation at this extreme time and temperature combination is obviously high, as seen by the amount of red (dead) fluorescing bacteria.
Figure 9 -Representative confocal micrographs of a DFR control biofilm at 37°C for 30 minutes (A) compared to a heat shocked DFR biofilm at 80°C and 30 minutes (B). Live bacteria fluoresce green and dead bacteria fluoresce red. This image displays the high level of deactivation from the extreme heat shock time and temperature combination.
Shaker biofilms were also heat shocked for various durations at 80°C in order to verify the visual decrease in live bacteria as the heat shock protocol was increased. Figure 10A , 10B, and 10C displays 80°C heat shocked shaker biofilms for 1, 15, and 30 minute times respectively. As the heat shock time is increased, the amount of red fluorescing bacteria is increased and the amount of green fluorescing bacteria is decreased. This further supports that thermal shock of biofilms is an appropriate means of deactivation, and that specific time and temperature combinations result in different levels of deactivation. 
DFR Heat shock biofilms
Heat shock biofilms experienced the same growth and thermal protocols as the control biofilms, but differed by elevating the temperature to 50°C, 60°C, 70°C, or 80°C. At each temperature, durations of 1, 2, 5, 10, 15, 20, or 30 minutes were evaluated (Table 1) . Since complete deactivation of the DFR biofilms was never achieved, overall trends of log reduction and the sensitivity to heat shock time and temperature combinations was quantifiable via direct enumeration (Figure 11 ). In general, as heat shock time or temperature increased, the average log(CFU/cm 2 ) decreased. 
Discussion
In order to establish thermal deactivation as an innovative treatment for biofilm infected medical devices, it was necessary to determine the time and temperature combinations needed for death to occur and the log reduction trends that develop from them. Beginning with the shaker biofilms was an encouraging start because it was confirmed that heat alone could be an appropriate means of biofilm eradication.
There were issues, however, that needed to be addressed beyond the shaker biofilm trials. The shaker biofilms, once heat shocked, resulted in large rates of log reduction of viable bacteria. The thermal protocols were so successful at deactivating the biofilm regardless of the time or temperature of the heat shock that it resulted in log(CFU/cm 2 ) below the minimum quantifiable threshold of 1.12. There was not enough quantification sensitivity to establish what levels of log Time (min) reduction heat shocks were actually accomplishing. Another issue with the shaker biofilms was the high level of enumeration variability post heat shock, resulting in large standard deviations of log(CFU/cm 2 ). This could be attributed to variability in the biofilm's matrix concentration.
Visually the shaker biofilms differed in levels of clarity and viscosity based on changes in the amount of matrix grown. Many of a biofilm's resistance factors can be associated with the matrix -transport limitation, physiological gradients, QS signaling, etc. Having less matrix, could lead to the cells behaving more as the planktonic phenotype as opposed to the biofilm phenotype. The bacteria would not be triggering the stress response or up-regulating efflux pumps. Thermal shock would easily be able to sterilize the colony. As matrix levels increased, more resistance would develop -resulting in the large standard deviations seen. Switching to the more standardized DFR growth environment addressed both the quantification sensitivity and varying matrix issue.
DFR biofilms were denser (350 times higher grand mean for control bacteria concentration) than shaker biofilms and visually more viscous and tackier (more than twice as thick). The DFR controls verified the starting bacteria density to be statistically the same (Figure 7 ). Adding in thermal heat shock further verified that the biofilms were more robust than the shaker biofilms because the quantification sensitivity increased. Complete thermal deactivation of the biofilm was not seen with DFR biofilms because the starting concentration of matrix and bacteria were higher.
Ranging the temperature from 50°C to 80°C and heat shock durations from 1 to 30 minutes resulted in general trends showing log reduction in viable bacteria (Figure 11 ). The highest deactivation was approximately 6.6 average log reduction, occurring at the high end of the time and temperature combinations of 80°C for 30 minutes. The lowest deactivation was approximately 0.1 average log reduction, occurring at the low end of the time and temperature combination of 50°C and 1 minute. This was expected, and supports the hypothesis that biofilms are susceptible to thermal shock. Now when choosing a time and temperature protocol, one could predict the approximate amount of log reduction that will be seen in a similar P. aeruginosa biofilm.
Increasing either heat shock duration or temperature was successful at decreasing log(CFU/cm 2 ), however, temperature had a much more dramatic difference than increasing time alone.
Comparing the means using a one-way ANOVA Tukey-Kramer method showed that changing the heat shock time was not statistically different or significant for log(CFU/cm 2 ) ( Figure 12A ), while doing the same means comparison of the temperature increase shows a statistical difference ( Figure 12B ). This concludes that log reduction is more susceptible to temperature changes. As this treatment method is optimized, the temperature effect will be taken into consideration. The high temperature, short duration heat shocks may be more appropriate for patients, than the lower temperature and longer duration heat shocks. When linear expressions are correlated to log(CFU/cm 2 ) vs. temperature at each heat shock duration, a strong dependency on temperature can again be observed ( Figure 13 ). The linear regressions have R 2 values ranging from 0.71 to 0.9 and show similar slopes as temperature is increased. Further data analysis shows that plotting log(CFU/cm 2 ) vs. log(time) results in better linear regression than just plotting against time. An example for 60°C is found in Figure 14 . The log(CFU/cm 2 ) vs. time tracks linearly with an R 2 value of 0.49, while log(CFU/cm 2 ) vs. log(time)
has an R 2 value of 0.63. show that temperature will have a greater effect than time on the CFU/cm 2 as each is increased.
The amount of log reduction in viable bacteria count from thermal deactivation is as high, if not
higher, than what has been seen in developing biofilm treatment methods currently underway.
Many of the other treatment methods also depend on complementary means of treatment to have applicable effects on viable cell counts. For example, targeting an electric current to a biofilm alone resulted in no log reduction of live bacteria, but supplementing antibiotic with electrical current had a 0.5 log reduction (Jass and Lappin-Scott 1996) . Ultrasound only had merely a 1 log reduction on biofilm viability (P. aeruginosa specifically) (Ensing, Neut et al. 2006 ). Other harsher biofilm treatments, achieve slightly higher deactivation, but are difficult to use in a medial implant application. For example, chlorine is a common biofilm treatment in the water treatment and food industries -having a 3 log reduction for Salmonella spp. when exposed to 100 ppm Cl2 for 5 min (Joseph, Otta et al. 2001) . Oral plaque biofilms have been reduced 2 log using photodynamic therapy (Wood, Metcalf et al. 2006 ). All of these treatments, however, work in tandem with other treatments, are more severe, and do not reach the same level of log reduction as shown using heat alone.
Establishing the time and temperature combinations needed for various levels of viable bacteria log reduction was the first step towards the long-term goal of developing an innovative biofilm treatment method. Being able to characterize and predict reduction trends is important. Going forward with this treatment will lead to addressing synergistic effects that would be seen on log reduction when bringing in another method of deactivation. This heat shock approach is unique because it is one of the only mitigation techniques being explored that does not employ a complementary approach. Adding in, for example, antibiotics might shift the time and temperature combinations needed to reach the same levels of log reduction. A final issue to address would be the effect of multiple pathogens on the thermal protocol. It is often seen that biofilms are composed of more than one species of bacteria and each of these have a different mechanism and reaction to treatment methods. Considering antibiotics and multiple strains would also mimic clinical practices better since one would rarely experience a single strain biofilm or develop an infection and not be given antibiotics as part of treatment. Thermal deactivation is known to be effective for all planktonic strains and expectantly this would also be true for biofilm strains.
Conclusions and future investigations
Biofilm infection of implanted medical devices is an ongoing problem with no easy or readily available solution. While treatment methods have been pursued, none have been able to fully eradicate the issue. Complicating the problem is the fact that biofilms continue to increase in resistance to typical treatments such as antibiotics. Thermal deactivation would be an innovative method to mitigate biofilm infections. It uses heat to kill biofilms at the device interface. This heat would eventually be supplied wirelessly by immobilizing magnetic nanoparticles in a device coating and exposing an alternating magnetic field outside the body of the patient.
It was shown that varying heat shocks from 50°C to 80°C and durations of 1 to 30 minutes could deactivate DFR grown P. aeruginosa biofilms. In particular this research had the following results that align with the objectives discussed in the Long-term project goal section:
1. Biofilms were cultured in two different ways, shaker and DFR. They were both produced from an inoculum on the order of 10 9 CFU/mL that was established through a growth study.
2. Shaker biofilms resulted in an architecture that was less viscous and had less microscope slide coverage than DFR biofilms. Shaker biofilms were 25 to 45 µm thick and had an overall control concentration of 6.24 log(CFU/cm 2 ) while DFR biofilms were 50 to 100 µm thick and an overall control concentration of 8.553 log(CFU/cm 2 ). Thickness was evaluated using CLSM and viable bacteria were quantified using direct enumeration.
3. A water bath system was developed to heat shock shaker and DFR biofilms while minimizing thermal inertia and instantaneously applying a thermal shock. Shaker biofilms were heat shocked at the control temperature of 37°C and the extremes of the investigated temperature range of 50°C and 80°C and heat durations of 2, 10, or 30 minutes. DFR biofilms were heat shocked at the control temperature of 37°C and 50°C, 60°C, 70°C, and 80°C and times of 1, 2, 5, 10, 15, 20, and 30 minutes.
4. Heat shocking shaker biofilms resulted in a log reduction than was not quantifiable by direct enumeration (log(CFU/cm 2 ) ≤ 1.12; i.e. plate count less than 5 CFUs). DFR biofilms were therefore perused in order to use biofilms with higher initial bacteria concentration for a greater possibility of log reduction quantification. Heat shocked DFR biofilms had log reductions ranging from 0.1 to 6.6 depending on the time and temperature combination used in the thermal protocol. Further data analysis showed that a linear regression could be fit for cell death temperature dependence vs. log(time), resulting in Equations 3 or 4. This shows a strong temperature dependence on log reduction and gives the ability to approximate deactivation for the DFR biofilms, given a time and temperature combination. This research addresses a large problem in the medical world and leads to the long-term goal of developing an innovative treatment for biofilm infected medical devices.
